Merger Details - ESSA Bancorp Inc (Nasdaq: ESSA) is proposed to merge with CNB Financial Corporation under an agreement where ESSA shareholders will receive 0.8547 shares of CNB common stock for each outstanding share of ESSA common stock [1] Law Firm Background - Monteverde & Associates PC is a national class action securities firm headquartered in the Empire State Building, New York City, with a successful track record in trial and appellate courts, including the US Supreme Court [2] - The firm has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report [1][2] Investigation Information - Monteverde & Associates PC is investigating ESSA Bancorp Inc regarding the proposed merger with CNB Financial Corporation [1] - Shareholders with concerns or seeking additional information can contact the firm through their website or directly via email or telephone [3]

Palantir Technologies Inc PLTR joined the prestigious Nasdaq-100 index on Dec. 23, a milestone often seen as a vote of confidence for companies with promising growth trajectories.Yet, rather than boosting investor sentiment, the stock has since tumbled over 15%, vastly underperforming broader market benchmarks. For comparison, the SPDR S&P 500 ETF SPY slipped just 0.87%, while the tech-heavy Invesco QQQ Trust, Series 1 QQQ fell a modest 1.45% during the same period.High Expectations, Harsh RealityInclusion ...

Constellation stock is up! No, it’s down! Wait, who’s right? Turns out, they both are. In an unusual bit of symmetry, shares of two companies named “Constellation” are among both the S&P 500’s top gainers and losers Friday.  On the green side of the ledger is Constellation Energy (CEG), shares of which were recently up some 26%. That was good for the second-best performance in the benchmark index after Walgreens Boots Alliance (WBA). Driving the move was the news that the company agreed to buy privately ow ...

On Thursday, Truist initiated coverage on BioNTech SE BNTX, a famed COVID-19 vaccine maker, in collaboration with Pfizer Inc PFE.BioNTech is transitioning from a COVID-focused narrative to a story centered on oncology drug development and upcoming catalysts.The analyst, Asthika Goonewardene, writes that BNT327 is at the forefront, a promising drug in an innovative class that could challenge and potentially surpass the PD-1 category, which generated over $42 billion in 2023.Also Read: BioNTech Earns Upgrade ...

Wildfire Impact on Airlines - American Airlines, United Airlines, Southwest Airlines, JetBlue Airways, and other carriers have waived fees for flight changes for travelers booked to Los Angeles due to power outages, water shortages, and damage to over 10,000 homes and structures [3] - American Airlines allows rebooking without change fees or fare differences for flights to or from Hollywood Burbank Airport, Los Angeles International Airport, Ontario International Airport, and John Wayne Airport until January 20 [4] - Southwest Airlines permits rebooking within 14 days of original travel dates without additional charges and allows changes to other California cities such as Palm Springs, Santa Barbara, and San Diego [5] Delta Air Lines Sales Impact - Delta Air Lines has seen a decline in sales for flights to Los Angeles, one of its busiest hubs, due to the wildfires, though the impact is not expected to be significant to the quarter [5][6] - Delta's president noted that while there is a decline in sales, there is no wholesale reduction or uptick in cancellations, and demand often increases after natural disasters due to rebuilding efforts [6][7]

Arch Capital Group Ltd. (NASDAQ: ACGL ) has good fundamentals in the insurance industry and an impressive growth history. Thus, long-term investors should see its recent share price weakness as an opportunity to buy more shares at an attractive valuation.Labutes IR is a Fund Manager/Analyst specialized in the financial sector, with more than 18 years of experience in the financial markets. I have worked at several type of institutions in the industry, always at the buy side and related to portfolio manageme ...

In 2024, utility stocks staged a remarkable comeback, buoyed by the surging energy demands of data centers and the transformative impact of artificial intelligence (AI) across industries. Frank Holmes, CEO of U.S. Global Investors (NASDAQ:GROW), explores how this trend propelled massive gains for companies like Vistra and GE Vernova, which capitalized on the AI-driven shift toward electrification and decarbonization. Holmes also delves into the broader market dynamics of 2024, highlighting the interplay bet ...

Company Strategy - Amazon is discontinuing its "Prime Try Before You Buy" service, effective January 31, 2025, as part of CEO Andy Jassy's cost-cutting measures [1][2][3] - The service, previously known as Prime Wardrobe, was launched in 2017 and allowed Prime members to try clothing, shoes, and accessories before purchasing [5] - Amazon has been scaling back experimental projects, including a speedy brick-and-mortar delivery service, telehealth offerings, and a video-calling device for kids [3] Service Details - "Prime Try Before You Buy" was available exclusively to Amazon Prime members, who pay $139 annually for perks like speedy shipping and streaming services [5] - Users could test a mix of luxury, staple, and Amazon-owned brands and return unwanted items for free within seven days [6] - The service operated similarly to competitors like Stitch Fix, Rent the Runway, and Urban Outfitters' Nuuly [6] Reasons for Discontinuation - The service only scaled to a limited number of items and customers, making it less viable [4] - Customers are increasingly using AI-powered features like virtual try-on, personalized size recommendations, and improved size charts to ensure the right fit [4] - Amazon is redirecting users to its fashion homepage after the service's discontinuation [2] Broader Context - Amazon has initiated the largest layoffs in its history, cutting over 27,000 jobs between 2022 and 2024 as part of cost-reduction efforts [3] - The discontinuation of "Prime Try Before You Buy" aligns with the company's broader strategy to streamline operations and focus on scalable, technology-driven solutions [3][4]

ADMA Biologics (ADMA) shares have skyrocketed 275.7% in a year against the industry’s decline of 14.3%. The stock has also outperformed the sector and the S&P 500 during the aforementioned period.ADMA also hit a 52-week high of $23.64 on Nov. 11. The stupendous rally can be attributed to the company’s consistently strong quarterly performance and raised guidance.ADMA Outperforms Industry, Sector & S&P 500Image Source: Zacks Investment ResearchAsceniv’s Performance Fuels ADMA’s GrowthADMA Biologics markets p ...

Exelixis, Inc. (EXEL) announced that the FDA has notified it about an update to its supplemental new drug application (sNDA) for cabozantinib.The sNDA is seeking approval for cabozantinib for the treatment of adults with previously treated advanced pancreatic neuroendocrine tumors (pNET) and advanced extra-pancreatic (epNET).In November 2024, the FDA notified the company that the sNDA for cabozantinib for the treatment of adults with previously treated advanced pancreatic neuroendocrine tumors (pNET) and ad ...